Epidiolex sales, potential CBD treatment for PTSD and more: GW Pharma CEO

GW Pharmaceutical CEO Justin Gover tells “Mad Money” host Jim Cramer the company sold $300 million worth of its CBD-based epilepsy drug in 2019 and …